Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Petereit

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
Low interferon gamma producers are better treatment responders: a two-year follow-up of interferon beta-treated multiple sclerosis patientsH F Petereit, S Nolden, S Schoppe, et al.
Journal of Neurology|December 23, 2016
The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literatureS Jarius, P Eichhorn, D Franciotta, et al.
Der Nervenarzt|March 22, 2006
[Fatal familial insomnia: case presentation and discussion of typical clinical and imaging findings]A V Thomas, J C Klein, A Brockhaus-Dumke, et al.
Acta Neurologica Scandinavica|May 6, 2006
Stroke after initiation of interferon-beta treatment for relapsing-remitting disseminated white matter diseaseB Bosche, C Dohmen, P Impekoven, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2008
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis opticaS Jarius, D Franciotta, R Bergamaschi, et al.
Journal of the Neurological Sciences|February 1, 2003
Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosisH F Petereit, R Pukrop, F Fazekas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
No effect of intravenous immunoglobulins on cytokine-producing lymphocytes in secondary progressive multiple sclerosisH F Petereit, D Reske, R Pukrop, et al.
Neurological Research and Practice|December 16, 2020
S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version)H Tumani, H F Petereit, A Gerritzen, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
Low interferon gamma producers are better treatment responders: a two-year follow-up of interferon beta-treated multiple sclerosis patientsH F Petereit, S Nolden, S Schoppe, et al.
Journal of Neurology|December 23, 2016
The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literatureS Jarius, P Eichhorn, D Franciotta, et al.
Der Nervenarzt|March 22, 2006
[Fatal familial insomnia: case presentation and discussion of typical clinical and imaging findings]A V Thomas, J C Klein, A Brockhaus-Dumke, et al.
Acta Neurologica Scandinavica|May 6, 2006
Stroke after initiation of interferon-beta treatment for relapsing-remitting disseminated white matter diseaseB Bosche, C Dohmen, P Impekoven, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2008
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis opticaS Jarius, D Franciotta, R Bergamaschi, et al.
Journal of the Neurological Sciences|February 1, 2003
Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosisH F Petereit, R Pukrop, F Fazekas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
No effect of intravenous immunoglobulins on cytokine-producing lymphocytes in secondary progressive multiple sclerosisH F Petereit, D Reske, R Pukrop, et al.
Neurological Research and Practice|December 16, 2020
S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version)H Tumani, H F Petereit, A Gerritzen, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 3